Systemic lupus erythematosus with cytophagic histiocytic panniculitis successfully treated with high-dose glucocorticoids and cyclosporine A

Lupus. 2013 Mar;22(3):316-9. doi: 10.1177/0961203313476355.

Abstract

A 37-year-old male with systemic lupus erythematosus (SLE) presented with high fever, subcutaneous indurations, anemia, thrombocytopenia, elevated liver enzymes and hyperferritinemia. Skin biopsy revealed hemophagocytic histiocytes in the adipose tissues. The patient was diagnosed with SLE with cytophagic histiocytic panniculitis (CHP). Treatment with high-dose glucocorticoids and cyclosporine A induced remission of SLE and CHP. CHP is generally a systemic disorder affecting subcutaneous adipose tissues with a high mortality rate. However, based on the present and previously reported cases, we believe that intensive immunosuppression can ameliorate CHP that occurs as a skin manifestation of SLE.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cyclosporine / therapeutic use*
  • Glucocorticoids*
  • Histiocytes / pathology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / pathology
  • Male
  • Panniculitis / complications
  • Panniculitis / drug therapy*
  • Panniculitis / pathology

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclosporine